The regional distribution of binding sites on the GABAA receptor and their kinetic parameters were measured by quantitative autoradiography in brains from normal rats and rats with a portacaval shunt, a model of portal systemic encephalopathy in which GAB A neuro transmission may be altered. The ligands used were eHlflunitrazepam (a benzodiazepine-site agonist), [3H]_ Ro15-1788 (a benzodiazepine-site antagonist), eH]musci mol (a GABA-site agonist), and eSS]t-butylbicyclo phosphorothionate eSS-TBPS, a convulsant that binds to a site near the chloride channel). Some brains were ana lyzed by computerized image analysis and three dimensional reconstruction. The regional distribution of binding of the benzodiazepines was very similar, but the patterns obtained with eH]muscimol and eSS]TBPS were
different combinations can potentially provide a heterogeneous population of different receptor sub types. Autoradiography techniques have been de veloped to study the anatomic distribution of recep tor binding sites throughout the brain (Palacios et aI. , 1980; Penney et aI. , 1981; Unnerstall et aI. , 1981) . Comparisons made between the regional dis tribution of different ligands using autoradiography (Wamsley et aI. , 1983; Bowery et aI. , 1984; Olsen et aI., 1984 Olsen et aI., ,1990 provided further evidence for the ex istence of the different receptor subtypes described thus far, and suggested that as yet undescribed types existed. One aim of the present study was to compare binding to the three major sites quantita tively in a more comprehensive manner than in ear lier studies, using autoradiography as well as three dimensional reconstruction of the whole brain, to provide further information about anatomical heter ogeneity of the receptor subtypes.
Another objective was to measure kinetic param eters at a regional level. In previous studies, these have been measured mostly in membrane prepara tions or in whole brain sections wiped off the slide (Palacios et aI. , 1980; Young and Kuhar, 1980; Mohler and Richards, 1981) . Quantitative autoradi ography has been used to measure kinetic parame ters of flunitrazepam and muscimol in several brain areas, but results were reported from only one or two brain sections (Penney et aI., 1981; Pan et aI. , 1983; Toga et aI., 1986) . These studies led to the general belief that the affinities of binding for BZDs and muscimol are relatively homogeneous through out the brain Mohler and Richards, 1981; Olsen et aI. , 1990) . We wished to study this in more detail and also evaluate the feas ability of using quantitative autoradiography for this purpose.
Abnormalities in the GABAA receptor may be in volved in disease states such as hepatic encepha lopathy (for review, see Mans, 1991) . Patients with liver disease are known to be abnormally sensitive to the sedative effects of barbiturates and BZDs (Branch et aI., 1976; Bakti et aI. , 1987) . Further more, there are some reports of patients in coma responding to a BZD antagonist, Ro15-1788 (fluma zenil) (Grimm et aI., 1988; Ferenci et aI., 1989) .
Experimental studies have primarily sought changes in binding to the GABA and BZD sites on the GABAA receptor, but have produced conflicting results, possibly because widely different models of both acute and chronic hepatic encephalopathy were used (Baraldi and Zeneroli, 1982; Schafer et aI., 1983; Ferenci et aI. , 1987; Maddison et aI. , 1987; Zimmerman et aI., 1989) . In most of these experi ments, measurements were made on membrane ho-mogenates, thereby obscuring regional heterogene ity. Only the use of a method that preserves regional integrity, such as quantitative auto radiography, enables evaluation of binding in small nuclei with any degree of anatomical resolution. No such detailed studies have been done in chronic portal systemic encephalopathy.
Thus, the aims of this study were to learn more about the regional distribution of the different bind ing sites on the GABAA receptor; to measure the kinetic parameters of binding, Kd and Bmax, by means of quantitative autoradiography; and to de termine whether there were any alterations in bind ing after portacaval shunting, a model of chronic portal systemic encephalopathy. We used four ligands: eH]flunitrazepam (a BZD-site agonist), eH]Ro15-1788 (a BZD-site antagonist), eH]musci mol (a GABA-site agonist), and e 5 S]TBPS (binding to a site near the chloride channel on the receptor).
To make the closest possible comparisons, we used consecutive sections from the same brains in the four assays.
METHODS

Rats
Male Sprague-Dawley rats with a portacaval shunt or sham operation were bought from Zivic-Miller Laborato ries (Allison Park, PA, U.S.A.). They weighed 225-250 g at the time of surgery, and had free access to food and water until the day of killing 3 to 4 weeks later. [At this time, the rats are fully recovered from surgery and the biochemical abnormalities characteristic of shunting are established and stable (Mans et aI., 1983 (Mans et aI., ,1984 (Mans et aI., ,1990 ).] The rats were anesthetized with 4% halothane in air and im mediately decapitated. The brain was rapidly removed and sectioned on the same day. The liver-to-body weight ratio was determined as a confirmation of the sham or shunted state (Mans et aI., 1984) . This ratio (x 100) was 4.2 ± 0.3 (mean ± SD) and 2.6 ± 0.6 for the eight sham operated and eight shunted rats, respectively.
We have previously shown that the sham-operated rats (after recovery from surgery) are normal with regard to every biochemical, physiological, and behavioral param eter we have measured (Mans et ai. 1982 (Mans et ai. , 1983 (Mans et ai. , 1984 (Mans et ai. , 1987 (Mans et ai. , 1990 ). In addition, in this study, we examined bind ing of each ligand with autoradiography in preliminary experiments in at least two normal unoperated rats, and this confirmed that both quantitatively and qualitatively ligand binding in the sham-operated rats was indistin guishable from that in normal rats.
Brain sections
Brains were sectioned at -11 to -Boe at a thickness of 50 /Lm. The sections were thawed onto gelatin-coated slides and stored in a dessicator at 4°e overnight. The following morning the slides were stored at -700e until use within 10 weeks. (There was no effect of storage time on ligand binding.) Each brain was sectioned so that several sets of slides were obtained, each slide containing five sections from different levels of the brain, and with each of the five sections consecutive to the homologous section on the previous slide. One set of slides was used to measure binding of all four ligands at single concentrations, en abling the closest possible comparison among ligands. Each binding assay included a slide from all control and shunted rats, to eliminate interassay variation. The kinet ics of binding of [3H]flunitrazepam, [3H]RoI5-1788, and [3H]muscimol were measured using sets of consecutive slides and a range of ligand concentrations.
Additional brains were sectioned for computer analysis and reconstruction, using about 100 sections from each brain. 
Radioisotopes and chemicals
Binding assays
Incubation conditions are given in Table 1 . The opti mum preincubation, incubation, and rinse times and tem peratures were determined in preliminary experiments. Preincubation was found to increase specific binding in the case of [3H]muscimol but not [35S]TBPS; it was omit ted for the BZD-site ligands. Clonazepam was used to determine the nonspecific binding of the BZD ligands be cause it binds only to the central type BZD site; there fore, binding of flunitrazepam to the peripheral type BZD site was subtracted as nonspecific binding. Ro 15-1788 binds only to the central type (Mohler and Richards, 1981) .
Brain sections were incubated lying flat in shallow Pyrex glass dishes holding five slides and 60 ml of incu bation medium each. The dishes were shaken slowly on a rotary shaker during incubation. For preincubation and rinsing, the slides were held vertically in glass slide hold ers. After rinsing, the slides were immediately placed flat on an aluminum dish placed in a dry ice/ethanol bath at -30 to -50°C from which the slides were removed one by one for drying with a stream of dry air. After at least 4 h (to insure complete drying), the slides were packed with Ultrofilm (LKB Instruments, Gaithersburg, MD, U.S.A.) or, in the case of [35S]TBPS, with Kodak OMC film (Kodak, Wayne Laboratory, Chicago, IL, U.S.A.). The Ultrofilm was developed with Kodak D-19 devel oper, fixed in Kodak Rapid Fixer, rinsed, and dried. The Kodak OMC film was developed in an automat.
Quantitation of autoradiographs
A strip of calibrated 3H standards (supplied and cali brated by Amersham) was packed with each film in the case of the 3H-labeled ligands. For [35S]TBPS binding, 14C standards (Amersham) were used, which were cali brated in preliminary experiments by exposing them to film for various periods of time together with brain paste sections that had been incubated in various concentra tions of [35S]TBPS. Duplicate brain paste sections were wiped off the slides and the radioactivity determined by liquid scintillation counting. Plots of film optical density vs. radioactivity were then used to assign values of 35S radioactivity to each standard for future use.
Optical densities of brain areas were measured with a Tobias densitometer (Tobias, Ivyland, PA, U.S.A.) and converted to nCi/mg of tissue using the calibrated stan dards. Dividing by the specific activity gave the fmol/mg values. No correction was used to account for differential quenching by gray and white matter, because only areas containing predominantly gray matter were measured. Furthermore, binding of the tritiated BZDs and muscimol to white matter was found to be negligible, as previously reported (Palacios et aI., 1980; Young and Kuhar, 1980) , and nonspecific binding was very low, so that any error from differential quenching should not be a major factor (Herkenham and Sokoloff, 1984) . With regard to the por tacaval shunted rats, observed pathological changes pro vide no evidence of any alteration in myelination (Diemer et aI., 1977) . The rat brain atlas of Paxinos and Watson (Paxinos and Watson, 1986 ) and a set of brain sections stained with cresyl violet were used as an aid to localize brain areas.
The films used for computer analysis and brain recon struction were scanned with a computer-driven micro densitometer (Photoscan P-I000, Optronix, MA, U.S.A.) and the resulting color images of each section converted to units of fmol/mg using the standards for the film as described above. Each section image was then taken through a series of programs (Hibbard et aI., 1987) to prepare the images and reconstruct the brain into a three dimensional image. Rinse was in ice-cold buffer, followed by a dip in ice-cold distilled water. [3H]Muscimol binding was preceded by 20 min of preincubation at 4°C in the incubation buffer. To obtain kinetic parameters, binding was carried out in the presence of a range of concentrations of unlabeled ligand. Values shown are mean fmol/mg of tissue ± SD specific binding of six control rats. Brain areas are ranked in descending order of flunitrazepam binding. Nonspecific binding was below the detectable limit of the methods (3 fmol/mg) for flunitrazepam and Ro 15-1788. and 6 and 0.4 fmollmg for muscimol and TBPS, respectively. Because the same rat brains were used in all four ligand assays, not all areas were present for every ligand. [3H]R015-1788. [3H]muscimol. and [35S]_ TBPS. Sections from a single brain were used for the R015-1788. muscimol. and TBPS images; a separate brain was used for the flunitrazepam images. The first im age in each row is of the whole brain. fol lowed by axial cuts at successively deeper levels. Binding is shown in units of fmol/mg of tissue. according to the keys. The key for TBPS has been multi plied by 10.
Determination of kinetic parameters
Initially, brain paste sections from normal rats were used to determine what concentrations should be used to obtain a saturation curve, and to show that nonspecific binding increased linearly with increasing concentration. Slides holding adjacent brain sections were then incu bated at six to seven different concentrations, and three additional slides were used for nonspecific binding at three of those concentrations. The slides were packed with film and the fmol/mg determined as described above. Saturation plots of fmol/mg versus concentration were drawn and the Kd and Bmax obtained from Hanes-Woolf linearized plots (Segel, 1976) .
Statistical methods
Mean values obtained in the sham-operated and porta caval shunted rats were compared using repeated measures analysis of variance, and within-group differ ences among areas assessed with analysis of variance (SAS, Cary, NC, U.S.A.).
RESULTS
Comparison of ligand binding
Specific regional binding of [3H]tlunitrazepam, eH]Ro15-1788, eH]muscimol, and eSS]TBPS in control rats is shown in Table 2 and Figs. 1 and 2. Nonspecific binding was below the detectable limit «2% of the average binding) for eHltlunitrazepam and eHlRoI5-1788. In the case of [3H]muscimol and eSS]TBPS, nonspecific binding was 4 and 11% of the average, respectively; since it was homoge neous throughout the brain, it was subtracted from the total binding values in all brain areas.
The patterns of binding of eHltlunitrazepam and [3H]Ro 15-1788 were very similar; in fact, the auto radiographs were not distinguishable. Characteris tic features were high binding in the outer layers of the cerebral cortex, hippocampus, dentate gyrus, superior and inferior colliculus, substantia nigra, and amygdala. There was relatively less binding in the thalamic nuclei, caudate, and globus pallidus. In the superior colliculus, the superficial layer bound more BZD than the intermediate layer. In the cer ebellar gray, binding was higher in the molecular than in the granular layers. eH]Muscimol binding showed many differences in distribution compared with the BZD ligands. In particular, binding was relatively higher in several thalamic nuclei and lower in the hypothalamus, sub stantia nigra, and lower midbrain areas. Very little binding of eH]muscimol was detected in the brain stem. The pattern of binding in the cerebral cortical layers was similar to that seen with the BZDs. How ever, in the cerebellum, the density of labeling in the cortical layers showed a reversed distribution compared with the BZD ligands, i.e., binding was much higher in the granular than in the molecular layers. This reversal in pattern has been noted in earlier studies (Wamsley et aI., 1988; Olsen et aI., 1990) . In general, binding of eHlmuscimol in the cerebellum was much higher than in the cerebrum.
Binding of the Cl-channel site ligand, esS] TBPS, was found to differ from both the BZD ligands and muscimol, in many brain areas. The most obvious differences were the relatively much lower binding in the cortex, hippocampus, and cer ebellum, and higher binding in the globus pallidus, thalamus, inferior colliculus, and brainstem. The outer layers of the cerebral cortex showed less J Cereb Blood Flow Metab, Vol. 12, No.2, 1992 (C) binding than the inner layers, the opposite of that found with the other ligands. The pattern was also reversed in the superior colliculus, where the inter mediate layer bound almost three times as much ligand as the superficial layer. The cerebellar layers showed a pattern closer to that of muscimol; how ever, the binding in the granular layer showed a gradient, with greater amounts bound near the white matter, and lesser amounts near the Purkinje cell layer. This pattern with TBPS has been noted previously (Gee et aI., 1983; Bowery et aI., 1984) .
Kinetic parameters
Regional Kd and Bmax values were successfully measured for eH]flunitrazepam, eH]Ro 15-1788, and eH]muscimol binding (Tables 3 and 4 ). ([35S]_ TBPS binding was found to be more variable, and could not be used to obtain kinetic parameters reli ably.)
A noteworthy finding was the regional heteroge neity of the Kd, which was statistically significant for all three ligands. The range of values was at least threefold in each case and appeared to be continu ous, i.e., the values did not seem to be clustered (Table 3 ). The Kd of eH]flunitrazepam correlated significantly with the Kd of eH]Ro 15-1788 (r = 0.76, p < 0.001), as did the Bmax (r = 0.97, p < 0.001), when plotted by brain region (Fig. 3) . This provided further confirmation that the differences seen among the regions were real. The parameters for eH]muscimol did not correlate with those of either of the two BZDs. (It is possible that differ ential quenching due to the differing white matter content of the structures examined could have made some contribution to the heterogeneity seen in the Bmax values; however, as discussed in the Methods section, this is unlikely to be a significant error for these structures. Differential quenching could not have been a factor in the heterogeneity in the Kd values.)
The Kd and Bmax values obtained for eH]Ro15-1788 and [3H]flunitrazepam were rather similar (al though the range of Kd was greater for eH]fluni trazepam). Therefore, the higher binding of eH]RoI5-1788 in Table 2 is to be expected, because twice the concentration of eH]Ro15-1788 was used (2 nM compared with 1 nM for eH]flunitrazepam; see Table 1 ).
Binding in portacaval shunted rats
Sections from shunted rats were included in all of the assays for the control rats. The nonspecific binding was found to be the same. Mean values for portacaval shunted rats (Table 5) were compared with the control values in Table 2 . There were no significant differences between the groups for any ligand in any brain region.
Whole brain images of specific binding of the four ligands in two shunted rat brains were recon structed as done for the control rat brain shown in Values shown are mean ± SO of six rats, in nM. Brain areas are ranked in descending order offlunitrazepam values. Because the same rat brains were used in all three ligand assays, not all areas were present for every ligand. The differences among the regions within each ligand were significantly different (analysis of variance, p = 0.01,0.0009, and 0.0001 for RoI5-1788, flunitrazepam, and muscimol, respectively). Values shown are mean ± SD of six rats, in fmol/mg of tissue. Brain areas are ranked in descending order of flunitrazepam values. Because the same rat brains were used in all three ligand assays, not all areas were present for every ligand. The differences among the regions within each ligand were significantly different (analysis of variance, p = 0.0001). Fig. 1 , and compared with two reconstructed con trol brains. Detailed examination of these brains at many coronal and axial levels confirmed the ab sence of any qualitative or quantitative differences in binding (beyond individual variation) of each ligand (data not shown).
Similarly, no differences were found in the ki netic parameters between the sham-operated and shunted groups (data not shown), except for a lower Bmax value in the amygdaloid complex [sham: 883 ± 355 fmol/mg (mean ± SD); shunt: 661 ± 196 fmoll mg] with eH]flunitrazepam binding, and lower Kd values in the caudate/putamen (sham: 3.0 ± 0.7 nM; shunt: 2.0 ± 0.5 nM) and cerebellar gray granular layer (sham: 3.3 ± 0.9 nM; shunt: 2.1 ± 0.7 nM) with eH]Ro 15-1788 binding.
DISCUSSION
Distribution of binding of ligands
Significant regional heterogeneity in the distribu tion of binding of the different ligands was found. Some of the differences observed in our study have been described in earlier studies (Wamsley et aI., 1983 (Wamsley et aI., ,1988 Olsen et aI., 1990) . Many additional dif ferences were noted. Binding of the two BZDs showed a very similar distribution. We included Ro 15-1788 in our study because, unlike fluni trazepam, its binding is not affected by endogenous GABA or CI-present in the tissue (Mohler and Richards, 1981; Richards and Mohler, 1984) . Be cause we did not preincubate the sections in the assays for BZD binding [and endogenous GABA is very difficult to remove and would not likely have diffused away completely during incubation McCabe et aI., 1988) ], any mod ulating effect of GAB A might have shown up as differences in the distribution or degree of binding between the two BZD ligands. There was no evi dence for any difference in distribution. Table 2 shows that, in each area, binding of flunitrazepam was 60 to 70% that of RoI5-1788. In the assay, one half of the concentration of flunitrazepam was used compared with Ro 15-1788 (and the kinetic parame ters were found to be very similar); therefore, one would expect about one-half the amount bound for flunitrazepam. The fact that it was 60 to 70% may reflect an effect of endogenous GABA on fluni trazepam binding; if it did, this effect was uniform.
Muscimol is a GABA agonist that binds to both high-affinity and low-affinity forms of the GABAA receptor. However, at 5 nM and under the condi tions used in our study, it should reflect binding to the high-affinity form. (There was no further de crease in specific binding when longer rinse times were used in preliminary experiments.) This is sup ported by the similarity of the pattern obtained in our experiments compared with earlier auto radio graphic studies (McCabe and Wamsley, 1986; Bow ery et aI., 1987) . The BZDs bind only to the low- affinity form (Costa et al., 1979; Browner et al., 1981) ; thus, the regional differences between the binding of the BZDs and muscimol should reflect differences in distribution of the two forms. The binding of TBPS clearly does not correlate with that of the BZD site or GAB A high-affinity site (as reflected by muscimol), when examined on a regional basis. Since both the BZD and muscimol sites are known to be associated with a CI-chan nel, TBPS does not appear to bind simply in pro portion to the number of Cl-channels. It has been suggested that the number of its binding sites is di rectly proportional to the number of GAB A-gated CI-channels that are open (Havoundjian et al., 1986) . Others found that TBPS binding to cortical membrane preparations was allosterically modu lated by drugs known to increase or decrease J Cereb Blood Flow Metab, Vol. 12, No. 2, 1992 GABAergic transmission, the effect depending on concentration, the presence or absence of GABA, and whether equilibrium or nonequilibrium condi tions were used (Lloyd et al., 1988; Abel et al., 1989; Sanna et al., 1990) . Clearly, more work needs to be done to clarify the relationship of TBPS bind ing to CI-channel function in vivo. If TBPS binding is indeed related to function rather than the mere presence of CI-channels, this could account for the unique picture of its distribution throughout the brain. Alternatively, the binding may be affected by modulatory influences by the various subunits that make up the receptor, and that may vary in different parts of the brain. In earlier less extensive studies, the binding of TBPS was reported to be similar to that of BZDs, although some differences were noted Wamsley et al., 1983; Mc Cabe and Wamsley, 1986) . Our results clearly can not support this conclusion.
When the known pathways of GABAergic trans mission are considered, there appears to be only partial correlation with the binding of any of the ligands, such as in the cerebral cortex and cerebel lum, where there is a high density of GABA inter neurons. Major GAB A projection pathways termi nate in the substantia nigra (from the basal ganglia), where only moderate ligand binding was seen, and the tectum (from the substantia nigra), where sig nificant binding was found in the superior collicu Ius. In the cerebellum, Purkinje fibers terminate in the deep cerebellar nuclei, which bound TBPS sig nificantly, but not the other ligands. The differences in distribution of BZD, muscimol, and TBPS bind ing in the cerebellar layers agree with reports of differential distribution of mR NA coding for the a and � subunits, two of the subunits that make up the GABAA receptor (R ichards et al., 1987; Siegel, 1988) . Comparison of the distribution of the differ ent ligands with that of glutamate dehydrogenase (GAD), the enzyme responsible for GABA synthe sis, likewise shows correspondence in some areas but not others. GAD is found in high concentrations in the cerebral cortex especially in the outer layers (Bowery et al., 1987) , thus comparing well with the distribution of BZD and muscimol binding, but not TBPS, which bound more highly in the lower layers in the cortex. There is a similar correspondence in the hippocampus, dentate gyrus, and in the superior colliculus, where GAD concentrations are highest in the superficial layer, again paralleling the distribu tion of the BZD ligands and muscimol, but not TBPS.
Regional kinetics of binding
Kinetic parameters of binding could be measured for three of the four ligands using quantitative au- Values shown are mean fmollmg of tissue ± SD specific binding of six rats 4 weeks after portacaval shunting. Brain areas are ranked in descending order of flunitrazepam binding in the control rats (Table 2) . See Table 2 for further details. There were no significant differences compared with the control values (repeated measures analysis of variance).
toradiography. The values obtained were in the same range as those reported in other studies, al though the data available allowed comparison with some areas or whole brain sections only (Palacios et aI., 1980; Young and Kuhar, 1980; Mohler and Rich ards, 198 1; Penney et al., 1981; Pan et al., 1983) .
The only exception was the Kd of muscimol, which was found to be 0.7-5.5 nM in our study, comparing reasonably well with �13 nM in whole brain sec tions in one study (Palacios et al., 1980) , but not with 35-59 nM in two other studies (Penney et al., 1981; Pan et al., 1983) . This discrepancy may be related to differences in technique; since muscimol binds to both the low-and high-affinity forms of the GABAA receptor, the conditions of the assay, es pecially the rinse time, can affect which form is predominantly reflected by the binding.
The most interesting finding was the distinct het erogeneity among brain regions in the Kd, for all three ligands. Earlier studies led to the conclusion that the Kd for the BZDs and muscimol was rela tively homogeneous throughout the brain (Pan et al., 1983; Toga et al., 1986; .
However, our results show a range of about three fold for RoI5-1788, fivefold for flunitrazepam, and almost eightfold for muscimol. The heterogeneity in the Kd of the BZDs does not seem to be due to differences in the effect of modulation of the BZD site by endogenous GABA, because it is also seen with RoI5-1788, the binding of which is apparently not influenced by endogenous modulators as dis cussed above.
Effect of portacaval shunting
In this study, no changes were found in the quan titative binding of ligands to the three major sites on the GABAA receptor in all rat brain regions studied, 3 to 4 weeks after portacaval shunting. Similarly, except for a few differences, there were no signifi cant effects of portacaval shunting on the regional binding affinity (Kd) or density (Bmax) of eH]fluni trazepam, eH]Ro 15-1788, and eH]muscimol bind ing. GAB A is known to increase the binding of flunitrazepam in a dose-dependent manner (Tall man et al., 1978; Unnerstall et al., 1981) . Therefore, the unchanged binding we found with eH]fluni trazepam in the shunted rats suggests that there were no significant alterations in synaptic concen trations of endogenous GABA. (As discussed above, endogenous GABA is very difficult to re move and is unlikely to have completely diffused away during the incubation at 4°C.)
The use of quantitative autoradiography in this study enabled a comparison of binding to be made at a detailed regional level, which was not possible in most of the earlier studies in which whole brain homogenates were used. Furthermore, the tissue was subjected to a much less traumatic procedure.
Fresh, frozen tissue simply sectioned and thaw mounted onto slides was used, in which the state of the receptor ought to reflect more closely that ex isting in vivo. There is one study in which autora diography was used to study flunitrazepam and muscimol binding in rabbits treated with galactos amine to produce acute hepatic failure (RossIe and Deckert, 1988) . Results from six areas in the cere bral cortex, hippocampus, and cerebellum obtained from just two brain sections were reported; no changes in binding were found.
Our findings of largely unaltered binding to the GAB A and BZD sites in a model of chronic portal systemic encephalopathy are in agreement with several other studies of various experimental mod els (Giguere et aI., 1988; Roy et aI., 1988; Zimmer man et aI., 1989) , and postmortem brain tissue (But terworth et aI., 1988) . Other contrasting studies showing altered binding may have been flawed by the use of detergents, which was found to cause artificial alterations in binding (RossIe et aI., 1989) .
The evidence, therefore, seems to be generally in favor of unchanged binding to the GABA and BZD sites, although extrapolation to all brain areas in all models should be made with caution. Binding of Recently, it has been suggested that there may be an endogenous or exogenous ligand for the BZD site present in abnormally high amounts, during he patic encephalopathy (Bassett et aI., 1987; Mullen et aI., 1989; Olasmaa et aI., 1989; Basile et aI., 1990) , and indeed patients have been treated with RoI5-1788, with mixed results (Ferenci et aI., 1989; Van der Rijt et aI., 1989) . The unchanged binding observed with the BZD ligands in our study does not support this hypothesis in the case of the por tacaval shunted rat, because the extra amount of ligand would have lowered the binding of the la beled BZDs by competition. The presence of such a ligand may depend on the model or condition being studied, as suggested by the equivocal findings in other studies (Bassett et aI., 1987; Zieve et aI., 1987; Olasmaa et aI., 1989; Basile et aI., 1990; Van der Rijt et aI., 1990) .
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Concluding remarks
The use of quantitative autoradiography in con secutive sections from the same brains enabled close comparison of qualitative and quantitative an atomical differences in the binding of ligands to the GABAA receptor, including the measurement of ki netic parameters in significant detail. The heteroge neity found in the distribution of binding of the var ious ligands and their kinetic parameters provides evidence for the existence of even greater multiplic ity in GABAA receptor subtypes than considered previously, with different distributions and affini ties for the various ligands throughout the brain.
Only minor alterations in binding were found in a model of portal systemic encephalopathy, the por tacaval shunted rat.
